Oscar Health (OSCR) stock plunged 12.7% after Wells Fargo downgraded it to “underweight” with a price target of $10, citing concerns about rising medical costs and pricing inadequacies for 2025.

Barclays also initiated coverage on OSCR with an “underweight” rating and a price target of $17, highlighting policy risks that could impact the insurer’s growth targets.

Despite potential in OSCR, some investors see greater promise in AI stocks for higher returns with limited downside risk, suggesting looking into other investment opportunities for better results.

Read more at Yahoo Finance: Oscar Health (OSCR) Loses 12.7% as Wells Fargo Downgrades Stock